S2908 Adherence to HBV Screening and Reactivation Prevention Protocols in Patients Receiving Anti-CD20 Treatment
Publication
, Conference
Lodha, S; Wegermann, K; King, L; Muir, A; Henson, JB
Published in: American Journal of Gastroenterology
October 2025
Duke Scholars
Published In
American Journal of Gastroenterology
DOI
EISSN
1572-0241
ISSN
0002-9270
Publication Date
October 2025
Volume
120
Issue
10S2
Start / End Page
S625 / S625
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lodha, S., Wegermann, K., King, L., Muir, A., & Henson, J. B. (2025). S2908 Adherence to HBV Screening and Reactivation Prevention Protocols in Patients Receiving Anti-CD20 Treatment. In American Journal of Gastroenterology (Vol. 120, pp. S625–S625). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.14309/01.ajg.0001139092.60328.63
Lodha, Shweta, Kara Wegermann, Lindsay King, Andrew Muir, and Jacqueline B. Henson. “S2908 Adherence to HBV Screening and Reactivation Prevention Protocols in Patients Receiving Anti-CD20 Treatment.” In American Journal of Gastroenterology, 120:S625–S625. Ovid Technologies (Wolters Kluwer Health), 2025. https://doi.org/10.14309/01.ajg.0001139092.60328.63.
Lodha S, Wegermann K, King L, Muir A, Henson JB. S2908 Adherence to HBV Screening and Reactivation Prevention Protocols in Patients Receiving Anti-CD20 Treatment. In: American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2025. p. S625–S625.
Lodha, Shweta, et al. “S2908 Adherence to HBV Screening and Reactivation Prevention Protocols in Patients Receiving Anti-CD20 Treatment.” American Journal of Gastroenterology, vol. 120, no. 10S2, Ovid Technologies (Wolters Kluwer Health), 2025, pp. S625–S625. Crossref, doi:10.14309/01.ajg.0001139092.60328.63.
Lodha S, Wegermann K, King L, Muir A, Henson JB. S2908 Adherence to HBV Screening and Reactivation Prevention Protocols in Patients Receiving Anti-CD20 Treatment. American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2025. p. S625–S625.
Published In
American Journal of Gastroenterology
DOI
EISSN
1572-0241
ISSN
0002-9270
Publication Date
October 2025
Volume
120
Issue
10S2
Start / End Page
S625 / S625
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1103 Clinical Sciences